BBA Clinical Diagnostic Lab Test Negotiated Rulemaking To Begin July 13
This article was originally published in The Gray Sheet
Executive Summary
Clinical diagnostic laboratory tests whose medical utility or clinical effectiveness is considered "controversial" will be among the specific types of tests for which national coverage policies are to be developed through negotiated rulemaking, the Health Care Financing Administration says in a June 3 Federal Register notice.